Carol D. Karp - Net Worth and Insider Trading

Carol D. Karp Net Worth

The estimated net worth of Carol D. Karp is at least $0 dollars as of 2024-12-28. Carol D. Karp is the Chief Regulatory Officer of Prothena Corp PLC and owns about 0 shares of Prothena Corp PLC (PRTA) stock worth over $0. Details can be seen in Carol D. Karp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carol D. Karp has not made any transactions after 2023-10-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Carol D. Karp

To

Carol D. Karp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carol D. Karp owns 1 companies in total, including Prothena Corp PLC (PRTA) .

Click here to see the complete history of Carol D. Karp’s form 4 insider trades.

Insider Ownership Summary of Carol D. Karp

Ticker Comapny Transaction Date Type of Owner
PRTA Prothena Corp PLC 2023-10-04 Chief Regulatory Officer

Carol D. Karp Latest Holdings Summary

Carol D. Karp currently owns a total of 1 stock. Carol D. Karp owns 0 shares of Prothena Corp PLC (PRTA) as of October 4, 2023, with a value of $0.

Latest Holdings of Carol D. Karp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PRTA Prothena Corp PLC 2023-10-04 0 15.14 0

Holding Weightings of Carol D. Karp


Carol D. Karp Form 4 Trading Tracker

According to the SEC Form 4 filings, Carol D. Karp has made a total of 8 transactions in Prothena Corp PLC (PRTA) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Prothena Corp PLC is the sale of 5,000 shares on October 4, 2023, which brought Carol D. Karp around $233,100.

Insider Trading History of Carol D. Karp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carol D. Karp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carol D. Karp Ownership Network

Ownership Network List of Carol D. Karp

No Data

Ownership Network Relation of Carol D. Karp

Insider Network Chart

Carol D. Karp Owned Company Details

What does Prothena Corp PLC do?

Who are the key executives at Prothena Corp PLC?

Carol D. Karp is the Chief Regulatory Officer of Prothena Corp PLC. Other key executives at Prothena Corp PLC include See Remarks Karin L Walker , Chief Operating Officer Brandon S. Smith , and Chief Legal Officer Michael J Malecek .

Prothena Corp PLC (PRTA) Insider Trades Summary

Over the past 18 months, Carol D. Karp made 4 insider transaction in Prothena Corp PLC (PRTA) with a net sale of 20,000. Other recent insider transactions involving Prothena Corp PLC (PRTA) include a net sale of 35,000 shares made by Karin L Walker , a net sale of 16,000 shares made by Brandon S. Smith , and a net sale of 15,000 shares made by Michael J Malecek .

In summary, during the past 3 months, insiders sold 0 shares of Prothena Corp PLC (PRTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,000 shares of Prothena Corp PLC (PRTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 105,000 shares.

Prothena Corp PLC (PRTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Prothena Corp PLC Insider Transactions

No Available Data

Carol D. Karp Mailing Address

Above is the net worth, insider trading, and ownership report for Carol D. Karp. You might contact Carol D. Karp via mailing address: C/o Prothena Biosciences Inc, 331 Oyster Point Boulevard, South San Francisco Ca 94080.

Discussions on Carol D. Karp

No discussions yet.